Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes.

Bradford ST, Nair SS, Statham AL, van Dijk SJ, Peters TJ, Anwar F, French HJ, von Martels JZH, Sutcliffe B, Maddugoda MP, Peranec M, Varinli H, Arnoldy R, Buckley M, Ross JP, Zotenko E, Song JZ, Stirzaker C, Bauer DC, Qu W, Swarbrick MM, Lutgers HL, Lord RV, Samaras K, Molloy PL, Clark SJ.

Sci Rep. 2019 Jul 2;9(1):9511. doi: 10.1038/s41598-019-45777-w.

2.

Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.

Newell F, Patel K, Gartside M, Krause L, Brosda S, Aoude LG, Loffler KA, Bonazzi VF, Patch AM, Kazakoff SH, Holmes O, Xu Q, Wood S, Leonard C, Lampe G, Lord RV, Whiteman DC, Pearson JV, Nones K, Waddell N, Barbour AP.

BMC Med Genomics. 2019 Feb 4;12(1):31. doi: 10.1186/s12920-019-0476-9.

3.

Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus.

Shah AK, Hartel G, Brown I, Winterford C, Na R, Cao KL, Spicer BA, Dunstone MA, Phillips WA, Lord RV, Barbour AP, Watson DI, Joshi V, Whiteman DC, Hill MM.

Mol Cell Proteomics. 2018 Dec;17(12):2324-2334. doi: 10.1074/mcp.RA118.000734. Epub 2018 Aug 10.

PMID:
30097534
4.

Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.

Forner PM, Ramacciotti T, Farey JE, Lord RV.

Obes Surg. 2017 Dec;27(12):3306-3313. doi: 10.1007/s11695-017-2939-4.

PMID:
29018990
5.

MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.

Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ.

World J Gastroenterol. 2017 Aug 14;23(30):5508-5518. doi: 10.3748/wjg.v23.i30.5508.

6.

Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.

Maag JLV, Fisher OM, Levert-Mignon A, Kaczorowski DC, Thomas ML, Hussey DJ, Watson DI, Wettstein A, Bobryshev YV, Edwards M, Dinger ME, Lord RV.

Mol Cancer Res. 2017 Nov;15(11):1558-1569. doi: 10.1158/1541-7786.MCR-17-0332. Epub 2017 Jul 27.

7.

Oesophageal Adenocarcinoma: A Patient and Physician's Perspective.

Maule D, Boccola M, Lord RV.

Oncol Ther. 2017;5(1):79-84. doi: 10.1007/s40487-017-0044-4. Epub 2017 Apr 19.

8.

Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.

Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV.

United European Gastroenterol J. 2017 Feb;5(1):13-20. doi: 10.1177/2050640616650794. Epub 2016 Jul 7.

9.

CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy.

Fisher OM, Levert-Mignon AJ, Lehane CW, Botelho NK, Maag JL, Thomas ML, Edwards M, Lord SJ, Bobryshev YV, Whiteman DC, Lord RV.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):746-754. Epub 2016 Aug 30.

PMID:
27577713
10.

Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.

Farey JE, Fisher OM, Levert-Mignon AJ, Forner PM, Lord RV.

Obes Surg. 2017 Mar;27(3):578-585. doi: 10.1007/s11695-016-2321-y.

11.

Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids.

Farey JE, Preda TC, Fisher OM, Levert-Mignon AJ, Stewart RL, Karsten E, Herbert BR, Swarbrick MM, Lord RV.

Obes Surg. 2017 Feb;27(2):399-407. doi: 10.1007/s11695-016-2302-1.

12.

Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.

Krause L, Nones K, Loffler KA, Nancarrow D, Oey H, Tang YH, Wayte NJ, Patch AM, Patel K, Brosda S, Manning S, Lampe G, Clouston A, Thomas J, Stoye J, Hussey DJ, Watson DI, Lord RV, Phillips WA, Gotley D, Smithers BM, Whiteman DC, Hayward NK, Grimmond SM, Waddell N, Barbour AP.

Carcinogenesis. 2016 Apr;37(4):356-65. doi: 10.1093/carcin/bgw018. Epub 2016 Feb 10.

13.

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.

Fisher OM, Lord SJ, Falkenback D, Clemons NJ, Eslick GD, Lord RV.

Gut. 2017 Mar;66(3):399-410. doi: 10.1136/gutjnl-2015-310888. Epub 2016 Jan 5. Review.

14.

Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma.

Greene CL, Worrell SG, Attwood SE, Chandrasoma P, Chang K, DeMeester TR, Lord RV, Montgomery E, Pech O, Vallone J, Vieth M, Wang KK, DeMeester SR.

J Gastrointest Surg. 2016 Apr;20(4):851-60. doi: 10.1007/s11605-015-3056-0. Epub 2015 Dec 21. Review.

PMID:
26691147
15.

Bariatric Surgery Provides a "Bridge to Transplant" for Morbidly Obese Patients with Advanced Heart Failure and May Obviate the Need for Transplantation.

Lim CP, Fisher OM, Falkenback D, Boyd D, Hayward CS, Keogh A, Samaras K, MacDonald P, Lord RV.

Obes Surg. 2016 Mar;26(3):486-93. doi: 10.1007/s11695-015-1789-1.

PMID:
26163362
16.

Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.

Bahin FF, Jayanna M, Hourigan LF, Lord RV, Whiteman D, Williams SJ, Lee EY, Bourke MJ.

Gastrointest Endosc. 2016 Jan;83(1):68-77. doi: 10.1016/j.gie.2015.04.044. Epub 2015 Jun 18.

PMID:
26096759
17.

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Fisher OM, Levert-Mignon AJ, Lord SJ, Lee-Ng KK, Botelho NK, Falkenback D, Thomas ML, Bobryshev YV, Whiteman DC, Brown DA, Breit SN, Lord RV.

Br J Cancer. 2015 Apr 14;112(8):1384-91. doi: 10.1038/bjc.2015.100. Epub 2015 Mar 17.

18.

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.

Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J, Eslick GD, Gordon LG, Grimpen F, Hebbard G, Holliday L, Hourigan LF, Kendall BJ, Lee EY, Levert-Mignon A, Lord RV, Lord SJ, Maule D, Moss A, Norton I, Olver I, Pavey D, Raftopoulos S, Rajendra S, Schoeman M, Singh R, Sitas F, Smithers BM, Taylor AC, Thomas ML, Thomson I, To H, von Dincklage J, Vuletich C, Watson DI, Yusoff IF.

J Gastroenterol Hepatol. 2015 May;30(5):804-20. doi: 10.1111/jgh.12913. Review.

PMID:
25612140
19.

Early metal stent insertion fails to prevent stricturing after single-stage complete Barrett's excision for high-grade dysplasia and early cancer.

Holt BA, Jayasekeran V, Williams SJ, Lee EY, Bahin FF, Sonson R, Lord RV, Bourke MJ.

Gastrointest Endosc. 2015 Apr;81(4):857-64. doi: 10.1016/j.gie.2014.08.022. Epub 2014 Oct 16.

PMID:
25442084
20.

Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.

Nones K, Waddell N, Wayte N, Patch AM, Bailey P, Newell F, Holmes O, Fink JL, Quinn MCJ, Tang YH, Lampe G, Quek K, Loffler KA, Manning S, Idrisoglu S, Miller D, Xu Q, Waddell N, Wilson PJ, Bruxner TJC, Christ AN, Harliwong I, Nourse C, Nourbakhsh E, Anderson M, Kazakoff S, Leonard C, Wood S, Simpson PT, Reid LE, Krause L, Hussey DJ, Watson DI, Lord RV, Nancarrow D, Phillips WA, Gotley D, Smithers BM, Whiteman DC, Hayward NK, Campbell PJ, Pearson JV, Grimmond SM, Barbour AP.

Nat Commun. 2014 Oct 29;5:5224. doi: 10.1038/ncomms6224.

21.

High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.

Fisher OM, Levert-Mignon AJ, Lord SJ, Botelho NK, Freeman AK, Thomas ML, Falkenback D, Wettstein A, Whiteman DC, Bobryshev YV, Lord RV.

Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.

22.

Robot-assisted oesophageal and gastric surgery for benign disease: antireflux operations and Heller's myotomy.

Falkenback D, Lehane CW, Lord RV.

ANZ J Surg. 2015 Mar;85(3):113-20. doi: 10.1111/ans.12731. Epub 2014 Jul 9. Review.

PMID:
25039924
23.

Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001-2008.

Smith RC, Creighton N, Lord RV, Merrett ND, Keogh GW, Liauw WS, Currow DC.

Med J Aust. 2014 Apr 21;200(7):408-13.

PMID:
24794674
24.

Robot-assisted gastrectomy and oesophagectomy for cancer.

Falkenback D, Lehane CW, Lord RV.

ANZ J Surg. 2014 Oct;84(10):712-21. doi: 10.1111/ans.12591. Epub 2014 Apr 15. Review.

PMID:
24730691
25.

Esophageal dysmotility after laparoscopic gastric band surgery.

Le Page PA, Kwon S, Lord SJ, Lord RV.

Obes Surg. 2014 Apr;24(4):625-30. doi: 10.1007/s11695-013-1134-5.

PMID:
24258146
26.

Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery.

Samaras K, Viardot A, Botelho NK, Jenkins A, Lord RV.

Diabetologia. 2013 Dec;56(12):2564-72. doi: 10.1007/s00125-013-3033-7. Epub 2013 Sep 13.

PMID:
24114113
27.

Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.

Clemons NJ, Phillips WA, Lord RV.

Cancer Biol Ther. 2013 Sep;14(9):782-95. doi: 10.4161/cbt.25362. Epub 2013 Jun 17. Review.

28.

Take heart: bariatric surgery in obese patients with severe heart failure. Two case reports.

Samaras K, Connolly SM, Lord RV, Macdonald P, Hayward CS.

Heart Lung Circ. 2012 Dec;21(12):847-9. doi: 10.1016/j.hlc.2012.05.783. Epub 2012 Jun 27.

PMID:
22743291
29.

Structural alterations of the mucosa stroma in the Barrett's esophagus metaplasia-dysplasia-adenocarcinoma sequence.

Bobryshev YV, Killingsworth MC, Lord RV.

J Gastroenterol Hepatol. 2012 Sep;27(9):1498-504. doi: 10.1111/j.1440-1746.2012.07179.x.

PMID:
22591183
30.

Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance.

Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A, Lord RV, Hayward CS.

Diab Vasc Dis Res. 2013 Jan;10(1):40-8. doi: 10.1177/1479164112443375. Epub 2012 Apr 25.

PMID:
22535587
31.

Does antireflux surgery prevent progression of Barrett's esophagus?

Lord RV.

Minerva Chir. 2011 Feb;66(1):1-6. Review.

PMID:
21389920
32.

Musashi-1 expression in atherosclerotic arteries and its relevance to the origin of arterial smooth muscle cells: histopathological findings and speculations.

Bobryshev YV, Tran D, Botelho NK, Lord RV, Orekhov AN.

Atherosclerosis. 2011 Apr;215(2):355-65. doi: 10.1016/j.atherosclerosis.2011.01.013. Epub 2011 Jan 21.

PMID:
21296351
33.

Barrett's esophagus.

Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC.

J Gastroenterol Hepatol. 2011 Apr;26(4):639-48. doi: 10.1111/j.1440-1746.2010.06602.x. Review.

PMID:
21166712
34.

Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues.

Botelho NK, Schneiders FI, Lord SJ, Freeman AK, Tyagi S, Nancarrow DJ, Hayward NK, Whiteman DC, Lord RV.

Cancer Biol Ther. 2010 Jul 15;10(2):172-9. Epub 2010 Jul 26.

PMID:
20543560
35.

Expression of C1q complement component in Barrett's esophagus and esophageal adenocarcinoma.

Bobryshev YV, Lu J, Lord RV.

J Gastrointest Surg. 2010 Aug;14(8):1207-13. doi: 10.1007/s11605-010-1230-y. Epub 2010 May 22.

PMID:
20496011
36.

Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.

Bobryshev YV, Freeman AK, Botelho NK, Tran D, Levert-Mignon AJ, Lord RV.

Dis Esophagus. 2010 Sep;23(7):580-9. doi: 10.1111/j.1442-2050.2010.01061.x. Epub 2010 Apr 29.

PMID:
20459440
37.

The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.

Viardot A, Lord RV, Samaras K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2845-50. doi: 10.1210/jc.2009-2371. Epub 2010 Apr 7.

PMID:
20375213
38.

Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.

Samaras K, Botelho NK, Chisholm DJ, Lord RV.

Obesity (Silver Spring). 2010 May;18(5):884-9. doi: 10.1038/oby.2009.443. Epub 2009 Dec 17.

39.

Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health.

Samaras K, Botelho NK, Chisholm DJ, Lord RV.

Obes Surg. 2010 Jan;20(1):108-13. doi: 10.1007/s11695-009-9952-1. Epub 2009 Sep 9.

PMID:
19763711
40.

Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation.

Morton JR, Ansari N, Glanville AR, Meagher AP, Lord RV.

J Gastrointest Surg. 2009 Aug;13(8):1448-53. doi: 10.1007/s11605-009-0924-5. Epub 2009 May 22.

PMID:
19462212
41.

Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.

Azatian A, Yu H, Dai W, Schneiders FI, Botelho NK, Lord RV.

J Gastrointest Surg. 2009 Jun;13(6):1044-51. doi: 10.1007/s11605-009-0839-1. Epub 2009 Mar 10.

PMID:
19277794
42.

Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease.

Lord RV, DeMeester SR, Peters JH, Hagen JA, Elyssnia D, Sheth CT, DeMeester TR.

J Gastrointest Surg. 2009 Apr;13(4):602-10. doi: 10.1007/s11605-008-0754-x. Epub 2008 Dec 3.

PMID:
19050984
43.

Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus.

Bobryshev YV, Tran D, Killingsworth MC, Buckland M, Lord RV.

J Gastrointest Surg. 2009 Mar;13(3):442-50. doi: 10.1007/s11605-008-0746-x. Epub 2008 Nov 18.

PMID:
19015928
44.

Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma.

Bobryshev YV, Tran D, Killingsworth MC, Buckland M, Lord RV.

J Gastrointest Surg. 2009 Jan;13(1):44-53. doi: 10.1007/s11605-008-0613-9. Epub 2008 Aug 7.

PMID:
18685901
45.

Education and imaging. Gastrointestinal: The sign of Leser-Trélat.

Ho ML, Girardi PA, Williams D, Lord RV.

J Gastroenterol Hepatol. 2008 Apr;23(4):672. doi: 10.1111/j.1440-1746.2008.05375.x. No abstract available.

PMID:
18397494
46.

Response of the lower esophageal sphincter to gastric distention by carbonated beverages.

Hamoui N, Lord RV, Hagen JA, Theisen J, Demeester TR, Crookes PF.

J Gastrointest Surg. 2006 Jun;10(6):870-7.

PMID:
16769544
47.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
48.

The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.

Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallböhmer D, Schäfer H, Danenberg KD, Danenberg PV, Selaru FM, Baldus SE, Hölscher AH, Meltzer SJ, Schneider PM.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2113-7.

49.

Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.

Lord RV, Wickramasinghe K, Johansson JJ, Demeester SR, Brabender J, Demeester TR.

Surgery. 2004 Sep;136(3):633-40.

PMID:
15349112
50.

Role of retinoid X receptor mRNA expression in Barrett's esophagus.

Brabender J, Lord RV, Metzger R, Park J, Salonga D, Danenberg KD, Hölscher AH, Danenberg PV, Schneider PM.

J Gastrointest Surg. 2004 May-Jun;8(4):413-22.

PMID:
15120365

Supplemental Content

Support Center